MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

A novel small molecule STAT3 inhibitor SLSI-1216 suppresses

Arnicolide D Inhibits Triple Negative Breast Cancer Cell

Arnicolide D Inhibits Triple Negative Breast Cancer Cell

Lexatumumab (HGS 1018) is a TRAIL-R2 Agonist Antibody

DT2216 is a Selective PROTAC Degrader of BCL-XL

SD-1029 is a JAK2/STAT3 Activation Inhibitor

PDF) STAT3 suppresses transcription of proapoptotic genes in

Frontiers Eupalinolide J Suppresses the Growth of Triple

A novel small molecule STAT3 inhibitor SLSI-1216 suppresses